Nucleotide sequences derived from the genome of retroviruses...

Details Nucleotide sequences derived from the genome of retroviruses... Nucleotide sequences derived from the genome of retroviruses...

2006-04-04

2006-04-04

Winkler, Ulrike (Department: 1648)

Chemistry: natural resins or derivatives; peptides or proteins;

Peptides of 3 to 100 amino acid residues

C424S207100, C424S208100, C435S069100, C435S091200, C435S091200, C530S300000, C536S023720, C536S024300

Reexamination Certificate

active

07022814

ABSTRACT:
The present invention relates to polypeptides encoded by a nucleotide sequence from an HIV-1, HIV-2, or SIV viral genome, in which the nucleotide sequence is amplified from the viral genome using a pair of primers that contain sequences that are conserved between different HIV and SIV strains. The primers are insensitive to variations in the genomes of different HIV and SIV isolates and, therefore, can be used to amplify nucleotide sequences from HIV-1, HIV-2, and SIV strains. The invention also relates to antibodies directed against these polypeptides and methods and kits for diagnosing viral infection.

REFERENCES:
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4839288 (1989-06-01), Montagnier et al.
patent: 5008185 (1991-04-01), Bacus
patent: 5051496 (1991-09-01), Alizon et al.
patent: 5079351 (1992-01-01), Sninsky et al.
patent: 5176995 (1993-01-01), Sninsky et al.
patent: 5268268 (1993-12-01), Sninsky et al.
patent: 5688637 (1997-11-01), Moncany et al.
patent: 5786177 (1998-07-01), Moncany et al.
patent: 0 239 425 (1987-01-01), None
patent: 0 229 701 (1987-07-01), None
patent: 0 283 327 (1988-01-01), None
patent: 0 269 445 (1988-06-01), None
patent: 0 269 520 (1988-06-01), None
patent: 0 272 098 (1988-06-01), None
patent: 0 318 281 (1989-05-01), None
patent: 0 320 495 (1989-06-01), None
patent: 62-217161 (1987-09-01), None
patent: 63-294800 (1988-12-01), None
patent: WO 86/02383 (1986-04-01), None
patent: WO 87/07300 (1987-12-01), None
patent: WO 87/07906 (1987-12-01), None
patent: WO 88/01302 (1988-02-01), None
patent: WO 88/05440 (1988-07-01), None
Burgess et al. Possible dissociation of the heparin-binding and mitogenic activities of heparin binding growth factor-1 from its receptor-binding activities by site directed mutagenesis of a single lysine residue. Journal of Cell Biology. (1990) vol. 111.
Lazar et al. Transforming growth factor alpha; mutations of aspartic acid 47 and leucine 48 results in different biological activities. Molecular and Cellular Biology (1988) vol. 8, No. 3, p. 1247-1252.
Tao et al. Studies of aglycosylated chimeric mouse-human IgG. The Journal of Immunology (1989) vol. 143 No. 8, p. 2595-260.
Abaza et al. Effects of amino acid substitutions outside an antigenic site on protein binding to monoclonal antibodies of predetermined specificity obtained by peptide immunization: demonstration with region 94-100 (antigenic site 3) of myoglobin. Journal.
Nuss et al. Defining the requirements for an antibody epitope on influenza virus neuraminidase: How Tolarant are protein epitopes? Journal of Molecular Biology (1994) vol. 235, pp. 747-759.
di Marzo et al. Loss of a neutralizing epitope by a spontaneous point mutation in the V3 loop of HIV-1 isolated from an infected laboratory worker. Journal of Biological Chemistry (Dec. 1993) vol. 268, No. 34, pp. 25894-25901.
Chakrabarti et al., “Sequence of Simian Immunodeficiency Virus from Macaque and its Relationship to Other Human and Simian Retroviruses,”Nature, vol. 328, pp. 543-547 (1987).
Guyader et al., “Genome Organization and Transactivation of the Human Immunodeficiency Virus Type 2,”Nature, vol. 326, pp. 662-669 (1987).
Courqnaud et al., BIOSIS No. 37083316, “HIV2 Identification Through PCR,” p. 668, Section C, Conference Doc. C.660 (Jun. 4-9, 1989).
Korber et al., BIOSIS No. 37094484, “Comparison of New HIV-2 Viral Isolates by Southern Blot and PCR,” p. 1013, Section G, Conference Doc. No. W.G.P.22 (Jun. 4-9, 1989).
Rayfield et al., BIOSIS No. 37073639, “PCR Subtyping of HIV Infections Exhibiting Reactive Serologic Responses to HIV-1 and HIV-2,” p. 159, Section A, Conference Doc. Th.A.P.109 (Jun. 4-9, 1989).
Kemp et al., “Colorimetric Detection of Specific DNA Segments Amplified by Polymerase Chain Reactions,”Proc Natl. Acad. Sci. USA, vol. 86, pp. 2423-2427 (1989).
Meyerhans et al., “Temporal Fluctuations in HIV Quasispecies In Vivo Are Not Reflected by Sequential HIV Isolations,”Cell, vol. 58, pp. 901-910 (1989).
Maniatis et al., “Molecular Cloning-A Laboratory Manual,” Cold Spring Harbor Laboratory, pp. 412-421 (1982).
Wain-Hobson et al., “Nucleotide Sequence of the Aids Virus, LAV,”Cell, vol. 40, pp. 9-17 (1985).
Horsburgh, Jr., et al., “Duration of Human Immunodeficiency Virus Infection Before Detection of Antibody,”The Lancet, vol. 2, pp. 637-639 (1989).
Ou et al., “DNA Amplification for Direct Detection of HIV-1 in DNA of Peripheral Blood Mononuclear Cells,”Science, vol. 239, pp. 295-297 (1988).
Rayfield et al., “Mixed Human Immunodeficiency Virus (HIV) Infection in an Individual: Demonstration of Both HIV Type 1 and Type 2 Proviral Sequences by Using Polymerase Chain Reaction,”The Journal of Infectious Diseases,vol. 158, No. 6, pp. 1170-1176 (1988).
Hart et al.,The Lancet, pp. 596-599 (Sep. 10, 1988).
Guatelli et al.,Clin. Microbiol. Rev.,vol. 2, pp. 217-226 (1989).
Laurence, J., “Update: HIV-1 Gene Nomenclature,”AIDS Res. Human Retrovir.,4:vii-vii (1988).
Gallo, R.C. et al., “HIV/HTLV Gene Nomenclature,”Nature, 333:514 (1988).

Affiliated with

Also associated with

Rating

Nucleotide sequences derived from the genome of retroviruses... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nucleotide sequences derived from the genome of retroviruses..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleotide sequences derived from the genome of retroviruses... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3620212